ADMA Biologics Inc (ADMA)
Debt-to-assets ratio
Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
---|---|---|---|---|---|---|
Long-term debt | US$ in thousands | 72,337 | 130,594 | 142,833 | 94,866 | 92,969 |
Total assets | US$ in thousands | 488,678 | 329,182 | 348,461 | 276,253 | 207,673 |
Debt-to-assets ratio | 0.15 | 0.40 | 0.41 | 0.34 | 0.45 |
December 31, 2024 calculation
Debt-to-assets ratio = Long-term debt ÷ Total assets
= $72,337K ÷ $488,678K
= 0.15
The debt-to-assets ratio of ADMA Biologics Inc has exhibited a fluctuating trend over the past five years. Starting at 0.45 as of December 31, 2020, the ratio decreased to 0.34 by the end of 2021. Subsequently, it slightly increased to 0.41 in 2022 before dropping to 0.40 in 2023. Notably, there was a significant decline in the ratio to 0.15 by December 31, 2024, indicating a substantial reduction in the company's debt relative to its total assets. This suggests that ADMA Biologics Inc has become more efficient in managing its debt obligations and enhancing its financial stability by leveraging a lower proportion of debt in its capital structure.
Peer comparison
Dec 31, 2024